Literature DB >> 34273389

Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration.

Jens V Andersen1, Kia H Markussen2, Emil Jakobsen3, Arne Schousboe3, Helle S Waagepetersen3, Paul A Rosenberg4, Blanca I Aldana5.   

Abstract

Glutamate is the primary excitatory neurotransmitter of the brain. Cellular homeostasis of glutamate is of paramount importance for normal brain function and relies on an intricate metabolic collaboration between neurons and astrocytes. Glutamate is extensively recycled between neurons and astrocytes in a process known as the glutamate-glutamine cycle. The recycling of glutamate is closely linked to brain energy metabolism and is essential to sustain glutamatergic neurotransmission. However, a considerable amount of glutamate is also metabolized and serves as a metabolic hub connecting glucose and amino acid metabolism in both neurons and astrocytes. Disruptions in glutamate clearance, leading to neuronal overstimulation and excitotoxicity, have been implicated in several neurodegenerative diseases. Furthermore, the link between brain energy homeostasis and glutamate metabolism is gaining attention in several neurological conditions. In this review, we provide an overview of the dynamics of synaptic glutamate homeostasis and the underlying metabolic processes with a cellular focus on neurons and astrocytes. In particular, we review the recently discovered role of neuronal glutamate uptake in synaptic glutamate homeostasis and discuss current advances in cellular glutamate metabolism in the context of Alzheimer's disease and Huntington's disease. Understanding the intricate regulation of glutamate-dependent metabolic processes at the synapse will not only increase our insight into the metabolic mechanisms of glutamate homeostasis, but may reveal new metabolic targets to ameliorate neurodegeneration.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease (AD); Aspartate aminotransferase (AAT); Glutamate dehydrogenase (GDH); Glutamate-glutamine cycle; Glutamic acid; Huntington's disease (HD); Malate-aspartate shuttle (MAS); Neurotransmitter recycling

Mesh:

Substances:

Year:  2021        PMID: 34273389     DOI: 10.1016/j.neuropharm.2021.108719

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  27 in total

1.  Enhanced Cortical Metabolic Activity in Females and Males of a Slow Progressing Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Dipak Roy; Madhuri Puvvada; Sampath K T Kapanaiah; Anant Bahadur Patel
Journal:  Neurochem Res       Date:  2022-03-26       Impact factor: 3.996

2.  Clonidine and Brain Mitochondrial Energy Metabolism: Pharmacodynamic Insights Beyond Receptorial Effects.

Authors:  Roberto Federico Villa; Antonella Gorini; Federica Ferrari
Journal:  Neurochem Res       Date:  2022-01-31       Impact factor: 3.996

3.  The glutamate/GABA system in the retina of male rats: effects of aging, neurodegeneration, and supplementation with melatonin and antioxidant SkQ1.

Authors:  Darya V Telegina; Anna K Antonenko; Anzhela Zh Fursova; Nataliya G Kolosova
Journal:  Biogerontology       Date:  2022-08-15       Impact factor: 4.284

4.  Time and Brain Region-Dependent Excitatory Neurochemical Alterations in Bilateral Common Carotid Artery Occlusion Global Ischemia Model.

Authors:  Olubukola Benedicta Ojo; Zainab Abiola Amoo; Mary Tolulope Olaleye; Sushil Kumar Jha; Afolabi Clement Akinmoladun
Journal:  Neurochem Res       Date:  2022-08-25       Impact factor: 4.414

5.  β-Hydroxybutyrate and Medium-Chain Fatty Acids are Metabolized by Different Cell Types in Mouse Cerebral Cortex Slices.

Authors:  Jens V Andersen; Emil W Westi; Elliott S Neal; Blanca I Aldana; Karin Borges
Journal:  Neurochem Res       Date:  2022-08-23       Impact factor: 4.414

6.  AMPK Modulates the Metabolic Adaptation of C6 Glioma Cells in Glucose-Deprived Conditions without Affecting Glutamate Transport.

Authors:  Inês Belo do Nascimento; Marie Verfaillie; Gamze Ates; Pauline Beckers; Virginie Joris; Nathalie Desmet; Ann Massie; Emmanuel Hermans
Journal:  Cells       Date:  2022-05-31       Impact factor: 7.666

7.  Glioprotective Effects of Resveratrol Against BMAA-Induced Astroglial Dysfunctions.

Authors:  Filipe Renato Pereira Dias; Rômulo Rodrigo de Souza Almeida; Vanessa Sovrani; Natalie K Thomaz; Carlos-Alberto Gonçalves; André Quincozes-Santos; Larissa Daniele Bobermin
Journal:  Neurotox Res       Date:  2022-03-23       Impact factor: 3.911

8.  Rates of pyruvate carboxylase, glutamate and GABA neurotransmitter cycling, and glucose oxidation in multiple brain regions of the awake rat using a combination of [2-13C]/[1-13C]glucose infusion and 1H-[13C]NMR ex vivo.

Authors:  Laura M McNair; Graeme F Mason; Golam Mi Chowdhury; Lihong Jiang; Xiaoxian Ma; Douglas L Rothman; Helle S Waagepetersen; Kevin L Behar
Journal:  J Cereb Blood Flow Metab       Date:  2022-01-20       Impact factor: 6.960

9.  Neuronal Loss of the Glutamate Transporter GLT-1 Promotes Excitotoxic Injury in the Hippocampus.

Authors:  Theresa S Rimmele; Shaomin Li; Jens Velde Andersen; Emil W Westi; Alexander Rotenberg; Jianlin Wang; Blanca Irene Aldana; Dennis J Selkoe; Chiye J Aoki; Chris G Dulla; Paul Allen Rosenberg
Journal:  Front Cell Neurosci       Date:  2021-12-29       Impact factor: 5.505

10.  Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer's disease.

Authors:  Jens V Andersen; Niels H Skotte; Sofie K Christensen; Filip S Polli; Mohammad Shabani; Kia H Markussen; Henriette Haukedal; Emil W Westi; Marta Diaz-delCastillo; Ramon C Sun; Kristi A Kohlmeier; Arne Schousboe; Matthew S Gentry; Heikki Tanila; Kristine K Freude; Blanca I Aldana; Matthias Mann; Helle S Waagepetersen
Journal:  Cell Death Dis       Date:  2021-10-16       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.